Trial Profile
Pharmacokinetics of raltegravir co-administered with atazanavir: A phase I study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Feb 2017
Price :
$35
*
At a glance
- Drugs Raltegravir (Primary) ; Atazanavir
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacokinetics
- 22 Feb 2017 New trial record